0
0

Greater Access to Affordable Pharmaceuticals Act of 2001

1/16/2023, 3:33 PM

Congressional Summary of HR 1862

Greater Access to Affordable Pharmaceuticals Act of 2001 - Amends the Federal Food, Drug, and Cosmetic Act to provide for an accelerated date of approval for a generic drug application.

Allows a drug to be considered a bioequivalent to a listed drug if the effects of such drug and the listed drug do not show a significant difference based on certain tests or studies.

Sets forth requirements concerning the filing of a citizen petition review.

Revises provisions concerning: (1) abbreviated new drug applications and new drug applications with respect to the time required for approval and the certification that a patent is invalid or will not be infringed; and (2) filing an application.

Requires a report concerning the extent to which this Act has: (1) has enabled products to come to market in a fair and expeditious manner, consistent with the rights of patent owners under intellectual property law; and (2) has promoted lower prices of drugs and greater access to drugs through price competition..

Read the Full Bill

Current Status of Bill HR 1862

Bill HR 1862 is currently in the status of Bill Introduced since May 16, 2001. Bill HR 1862 was introduced during Congress 107 and was introduced to the House on May 16, 2001.  Bill HR 1862's most recent activity was Sponsor introductory remarks on measure. (CR H2110) as of May 7, 2002

Bipartisan Support of Bill HR 1862

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
62
Democrat Cosponsors
54
Republican Cosponsors
7
Unaffiliated Cosponsors
1

Policy Area and Potential Impact of Bill HR 1862

Primary Policy Focus

Health

Potential Impact Areas

- Administrative procedure
- Administrative remedies
- Civil actions and liability
- Commerce
- Competition
- Congress
- Congressional reporting requirements
- Consent decrees
- Department of Health and Human Services
- Drug approvals
- Drug industry
- Generic drugs
- Government Operations and Politics
- Government paperwork
- Governmental investigations
- Intellectual property
- Judicial opinions
- Law
- Patents
- Pharmaceutical research
- Prescription pricing
- Restrictive trade practices
- Right of petition
- Science, Technology, Communications

Alternate Title(s) of Bill HR 1862

Greater Access to Affordable Pharmaceuticals Act of 2001
To amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.
Greater Access to Affordable Pharmaceuticals Act of 2001

Comments

Latest Bills

Ending Importation of Russian Oil Act
Bill HR 6968March 11, 2026
Housing for the 21st Century Act
Bill HR 6644March 11, 2026
WORK to Save Lives Act
Bill S 3812March 11, 2026
Living Donor Protection Act of 2025
Bill S 1552March 11, 2026
SAVES Act of 2025
Bill S 1441March 11, 2026
HONOR Act
Bill S 327March 11, 2026
Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes.
Bill HR 7147March 11, 2026
A bill to prohibit the Department of Homeland Security from constructing, acquiring, renovating, or operating any new processing site or detention center without providing a mechanism for public comments regarding such activity, entering into a signed, written agreement with appropriate State and local officials, and providing Congress with advance notice of such activity.
Bill S 3894March 11, 2026
A bill to amend title 10, United States Code, to authorize representatives of veterans service organizations to participate in presentations to promote certain benefits available to veterans during preseparation counseling under the Transition Assistance Program of the Department of Defense, and for other purposes.
Bill S 3938March 11, 2026
A bill to amend the Elementary and Secondary Education Act of 1965 to expand access to school-wide arts and music programs, and for other purposes.
Bill S 4018March 11, 2026
Greater Access to Affordable Pharmaceuticals Act of 2002
Bill S 812January 16, 2023
Providing for consideration of the bill (H.R. 1862) to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.
Bill HRES 517January 16, 2023